Grade III meningioma with gastro-intestinal tract and brain metastases: case report and review of the literature.
Laura Bender SommeBenoit LhermitteHélène CarinatoSeyyid BalogluMehdi HelaliHélène CebulaDelphine AntoniGeorges NoelPublished in: World journal of surgical oncology (2019)
To our knowledge, this is the first case of meningioma GIT metastases. Also, we report the difficulty to confirm the diagnosis of meningioma metastases. Indeed, malignant meningioma has the same histopathological features as melanoma or carcinoma. The standard of care for the management of malignant meningioma is gross total surgery followed by postoperative radiotherapy. Metastatic meningioma is uncommon and no guidelines for the management of recurrent or metastatic meningioma have yet been published. However, several studies reported systemic therapeutic options such as antibody against VEGF, somatostatin analogs, PDGF-R, and VEGF-R tyrosine kinase inhibitors, in the case of recurrent or metastatic meningioma. We also made a review of the actual literature of systemic treatment options for metastatic meningioma.
Keyphrases
- optic nerve
- small cell lung cancer
- squamous cell carcinoma
- healthcare
- brain metastases
- endothelial cells
- systematic review
- randomized controlled trial
- vascular endothelial growth factor
- palliative care
- patients undergoing
- optical coherence tomography
- acute coronary syndrome
- rectal cancer
- pain management
- quality improvement
- angiotensin ii
- health insurance
- drug induced